Femara 2,5 mg 30 tablets

Femara 2.5 mg 30 tablets

Composition:

Active ingredient: letrozole 2.5 mg.
Excipients: lactose monohydrate, microcrystalline cellulose, corn starch, sodium starch glycolate, magnesium stearate, colloidal anhydrous silica, hypromellose (E464), talc, macrogol 8000, titanium dioxide (E171), yellow iron oxide (E172).

Product Description:

Femara contains letrozole, an aromatase inhibitor.
It is a hormonal (endocrine) therapy for breast cancer.
Letrozole reduces estrogen levels by blocking the aromatase enzyme, slowing or stopping the growth of estrogen‑dependent tumor cells.

Indications:

• Treatment of breast cancer in postmenopausal women.
• Prevention of breast cancer recurrence.
• First‑line therapy before surgery when immediate surgery is not suitable.
• Treatment after surgery or after a 5‑year course of tamoxifen.
• Prevention of tumor spread in advanced breast cancer.

Method of Administration and Dosage:

• Take strictly as prescribed by your doctor.
• Usual dose: 1 Femara tablet once daily.
• Take at the same time each day.
• Swallow the tablet whole with water.
• Treatment is long‑term — months or years, under regular medical supervision.
• In case of overdose — contact a doctor.
• If a dose is missed:
  if the next dose is due in 2–3 hours — skip the missed dose;
  otherwise take it as soon as remembered and continue the schedule;
  do not double the dose.
• Do not stop treatment unless instructed by your doctor.

Side Effects:

• Very common: hot flushes, increased cholesterol, fatigue, sweating, bone and joint pain.
• Common: skin rash, headache, dizziness, nausea, vomiting, dyspepsia, constipation, diarrhea, appetite changes, muscle pain, osteoporosis, swelling, depression, weight gain, hair loss, hypertension, abdominal pain, dry skin, vaginal bleeding, palpitations.
• Uncommon: weakness, paralysis, speech disturbances, sudden chest pain, vein inflammation, high fever, mouth ulcers, blurred vision, tendinitis.
• Rare: difficulty breathing, fainting, cyanosis, sudden limb pain (thrombosis), tendon rupture.
• Other: anxiety, irritability, memory problems, carpal tunnel syndrome, sensory disturbances, eye symptoms, itching, vaginal dryness, high temperature, dry mucous membranes, weight loss, urinary infections, cough, elevated enzymes, jaundice.
• Seek medical attention immediately if severe symptoms occur.

Contraindications:

• Allergy to letrozole or any excipient.
• Premenopausal status (menstruation still present).
• Pregnancy.
• Breastfeeding.

Warnings and Precautions:

• Severe kidney or liver disease.
• Osteoporosis or history of fractures.
• Possible tendon inflammation or injury.
• Inform your doctor about all medications you take.
• Use only after menopause.
• Do not use during pregnancy or breastfeeding.
• Avoid driving if dizzy or drowsy.
• Contains lactose — consult a doctor if intolerant to sugars.
• Contains less than 1 mmol sodium — essentially sodium‑free.
• May reduce bone density — bone density monitoring may be required.
• Inform your doctor about all medicines you are taking, including over‑the‑counter products.

Storage Conditions:

Store at temperatures not exceeding 30°C.

Packaging:

A carton box containing 3 blister packs of 10 tablets each and a paper leaflet.